NCT07117539

Brief Summary

The goal of this clinical trial is to assess the impact of laryngeal mask combined with visual bronchial blocker on pharyngolaryngeal injury after pulmonary resection in patients with pulmonary nodules. The main question it aims to answer is: the incidence of postoperative pharyngolaryngeal injury within 24h : sore throat and hoarseness ? Researchers will compare the visual bronchial blocker group (VBB) with the double-lumen endotracheal tube group (DLT) to see if the visual bronchial blocker group can minimize laryngopharyngeal injury after pulmonary resection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2025

Completed
27 days until next milestone

First Posted

Study publicly available on registry

August 12, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

August 18, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
Last Updated

January 15, 2026

Status Verified

January 1, 2026

Enrollment Period

2 months

First QC Date

July 16, 2025

Last Update Submit

January 13, 2026

Conditions

Keywords

pulmonary resectionone-lung ventilationpharyngolaryngeal injurieslung isolation devices

Outcome Measures

Primary Outcomes (1)

  • Incidence of pharyngolaryngeal injuries within postoperative 24 hours

    sore throat and hoarseness

    within postoperative 24 hours

Secondary Outcomes (10)

  • Incidence of pharyngolaryngeal injuries within postoperative an hour

    within postoperative an hour

  • Incidence of pharyngolaryngeal injuries within postoperative 48 hours

    within postoperative 48 hours

  • Intraoperative device displacement

    during the operation

  • Intraoperative hypoxemia

    during the operation

  • Lung collapse quality

    at 5, 10, and 20 minute during single-lung ventilation

  • +5 more secondary outcomes

Study Arms (2)

visual bronchial blocker group(VBB)

EXPERIMENTAL

Laryngeal Mask Airway(LMA) size selection based on patient weight (≥70kg: size 5, 50-70kg: size 4, \<50kg: size 3);Standard LMA insertion technique in supine position;Visual bronchial blocker inserted through LMA central channel;Blocker advancement under direct vision to identify carina

Device: visual bronchial blocker (VBB)

double-lumen endotracheal tube group(DLT)

ACTIVE COMPARATOR

Size selection based on patient gender and height: Male: \>180cm (37F), 160-180cm (35F), \<160cm (32-35F);Female: \>160cm (35F), \<155cm (32F), 155-160cm (individualized);Standard laryngoscopy and DLT insertion;Fiberoptic bronchoscopy confirmation of positioning;Tracheal cuff pressure 25 cmH2O, bronchial cuff pressure 30 cmH2O

Device: double-lumen endotracheal tube (DLT)

Interventions

lung isolation with visual bronchial blocker

visual bronchial blocker group(VBB)

lung isolation with double-lumen endotracheal tube

double-lumen endotracheal tube group(DLT)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Scheduled for elective VATS pulmonary resection under general anesthesia
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Body mass index (BMI) 18.5-30.0 kg/m²
  • Written informed consent

You may not qualify if:

  • Anticipated difficult airway (Mallampati class IV, previous difficult intubation, airway abnormalities)
  • Gastroesophageal reflux disease or gastric retention
  • Active pulmonary infection or bleeding
  • Severe pulmonary dysfunction (FEV1 \<50% predicted)
  • Previous lung surgery or bilateral lung surgery
  • Cognitive impairment affecting outcome assessment
  • Chronic throat pain or voice abnormalities within 24 hours preoperatively
  • Abnormal right upper lobe bronchial anatomy on preoperative CT for right-sided procedures
  • Any condition deemed unsuitable for study participation by anesthesiologist or surgeon

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Shanghai Chest Hospital

Shanghai, 200030, China

Location

Shanghai Pulmonary Hospital

Shanghai, 200433, China

Location

The Second Military Medical University Changhai Hospital

Shanghai, 200433, China

Location

Related Publications (1)

  • Zhang Y, Li T, Wei J, Bao R, Lv X, Wang JF, Wu J. Laryngeal mask airway combined with visual bronchial blocker versus double-lumen tube for lung isolation in video-assisted thoracoscopic surgery: a protocol for a multicentre randomised controlled trial. BMJ Open. 2025 Dec 30;15(12):e110539. doi: 10.1136/bmjopen-2025-110539.

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Jingxiang Wu

    Shanghai Chest Hospital

    STUDY DIRECTOR
  • Tingting Li

    Shanghai Chest Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Attending physician

Study Record Dates

First Submitted

July 16, 2025

First Posted

August 12, 2025

Study Start

August 18, 2025

Primary Completion

October 31, 2025

Study Completion

November 30, 2025

Last Updated

January 15, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations